Skip to main content

Table 3 Comparison of the disease severity, the virus negative conversion time and the prognosis among the four subgroups (nā€‰=ā€‰95)

From: Overall reduced lymphocyte especially T and B subsets closely related to the poor prognosis and the disease severity in severe patients with COVID-19 and diabetes mellitus

Variable

Non-DM group (nā€‰=ā€‰76)

DM group (nā€‰=ā€‰19)

Ļ‡2or F score

P score

Non-severe subgroup

(nā€‰=ā€‰57)

Severe subgroup

(nā€‰=ā€‰19)

Non-severe subgroup

(nā€‰=ā€‰8)

Severe subgroup

(nā€‰=ā€‰11)

virus negative conversion time

18.49ā€‰Ā±ā€‰10.02

20.53ā€‰Ā±ā€‰9.25

28.00ā€‰Ā±ā€‰12.84

27.73ā€‰Ā±ā€‰9.57

4.097

0.009

In-hospital time

14.25ā€‰Ā±ā€‰8.72

17.79ā€‰Ā±ā€‰12.33

19.38ā€‰Ā±ā€‰8.12

29.27ā€‰Ā±ā€‰16.59

6.704

ā€‰<ā€‰0.0001

Severe(case, %)

19(25.00)

11(61.11)

-2.940

0.003

Prognosis

Ā Ā 

-3.394

0.001

Ā Cured (case, %)

53(71.05)

5(26.32)

Ā Unhealed

21(26.32)

13(68.42)

Ā Death

2(2.63)

1(5.26)

  1. FPG, fasting plasma glucose; HbA1c, glycated hemoglobin A1c; DM, diabetes mellitus; non-DM, without diabetes mellitus